Lion Biotechnologies to Present at the 4th Annual Cancer Immunotherapy Conference
24 mars 2014 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, March 24, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based...
Lion Biotechnologies to Present at the BioCentury Future Leaders Conference
21 mars 2014 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, March 21, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based...
Lion Biotechnologies to Present at the 26th Annual ROTH Conference
04 mars 2014 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, March 4, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO) announced that Chief Executive Officer Manish Singh, Ph.D., will present at the 26th Annual ROTH Conference on...
Lion Biotechnologies Issues Letter to Shareholders
03 févr. 2014 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO) announced that Chairman and CEO, Manish Singh, Ph.D., has issued the following letter to the shareholders.
Dear...